Profilo
Philip James Bromley has founded a company called Virun, Inc. in the year 2003 and currently holds the title of Chief Executive Officer.
Posizioni attive di Philip James Bromley
| Società | Posizione | Inizio |
|---|---|---|
Virun, Inc.
 Virun, Inc. BiotechnologyHealth Technology Virun, Inc. develops effective drug delivery and food and beverage ingredients. Its products include OmegaH2O and Coenzyme Clear. The firm operates through three segments: food and beverage ingredient manufacturing, consumer product development and pharmaceutical drug delivery. The foods and beverage ingredient manufacturing segment produces novel food and beverage concentrates stemming from a patented portfolio. The consumer product development segment develops novel and patented consumer products that allow substantiated health claims. The pharmaceutical drug delivery segment utilizes its patented technologies to improve the pharmacokinetics (delivery) and dynamics (efficacy) of peptides and compounds that have poor oral bioavailability or over-all functionality. The company was founded in 2003 by Philip James Bromley and is headquartered in Walnut, CA. | Amministratore Delegato | 01/01/2003 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Virun, Inc.
Virun, Inc. BiotechnologyHealth Technology Virun, Inc. develops effective drug delivery and food and beverage ingredients. Its products include OmegaH2O and Coenzyme Clear. The firm operates through three segments: food and beverage ingredient manufacturing, consumer product development and pharmaceutical drug delivery. The foods and beverage ingredient manufacturing segment produces novel food and beverage concentrates stemming from a patented portfolio. The consumer product development segment develops novel and patented consumer products that allow substantiated health claims. The pharmaceutical drug delivery segment utilizes its patented technologies to improve the pharmacokinetics (delivery) and dynamics (efficacy) of peptides and compounds that have poor oral bioavailability or over-all functionality. The company was founded in 2003 by Philip James Bromley and is headquartered in Walnut, CA. | Health Technology |
- Borsa valori
- Insiders
- Philip James Bromley
